Nymalize — Class III drug recall D-1625-2020
Terminated recall by Arbor Pharmaceuticals Inc., reported 2020-10-07, distributed nationwide. Subpotent Drug
| Recall number | D-1625-2020 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Arbor Pharmaceuticals Inc., Atlanta, GA, United States |
| Recall initiated | 2020-09-16 |
| Classified | 2020-09-28 |
| Reported by FDA | 2020-10-07 |
| Terminated | 2022-02-22 |
| Distributed | Nationwide (US) |
| Quantity | 1,846 cartons |
| Reason classes | potency |
| NDC | 24338-0200-12 |
| Lot numbers | 356884 |
| Expiration dates | 2021-11-30 |
Product
Nymalize (nimodipine) oral solution, 60 mg/20 mL, 12 Unit-Dose Cups and 12 Oral Syringes, 2 inner cartons per outer shipping carton, Rx Only, Distributed by arbor Atlanta, GA, NDC 24338-200-12
Reason for recall
Subpotent Drug
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1625-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.